Capstone Financial Statements
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.44-0.145 (-9.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Capstone revenue and earnings
In fiscal 2025, Capstone generated $46.9 million in revenue, up 4.5% from fiscal 2024. Capstone reported a net loss of $21.2 million, compared with a loss of $2.6 million a year earlier. Gross margin was 23.0% (up from 21.3%) and operating margin -23.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Capstone income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 | FY 20152015-12-31 | FY 20142014-12-31 | FY 20132013-12-31 | FY 20122012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.88M | 44.88M | 48.35M | -2.00M | 0 | — | — | — | — | — |
| Revenue growth (YoY) | +4.47% | -7.19% | — | — | — | — | — | — | — | — |
| Cost of Revenue | 36.09M | 35.31M | 38.74M | — | — | — | — | — | — | — |
| Gross Profit | 10.79M | 9.57M | 9.61M | — | — | — | — | — | — | — |
| Operating Expenses | 21.78M | 10.21M | 10.87M | 2.18M | 1.68M | 1.58M | 2.94M | 4.52M | 4.29M | 4.15M |
| Research & Development | — | — | — | 52.00K | 1.04M | 1.04M | 1.18M | 3.07M | 1.00K | 9.00K |
| Selling, General & Admin | 14.37M | 10.21M | 10.87M | — | — | — | — | — | — | — |
| Operating Income | -10.99M | -638.00K | -1.26M | 181.00K | 1.68M | — | — | — | — | — |
| Interest Expense | 3.89M | 1.48M | 1.67M | — | — | — | — | — | — | — |
| Other Income (Expense) | — | — | 143.00K | 251.00K | 111.00K | -81.00K | -24.00K | -43.00K | — | — |
| Pretax Income | -14.05M | -2.12M | -3.58M | 432.00K | 1.79M | -1.67M | -2.96M | -4.57M | -4.13M | -4.05M |
| Income Tax | 7.18M | 442.00K | 234.00K | 52.00K | 36.00K | -56.00K | -192.00K | -400.00K | -21.00K | 0 |
| Net Income | -21.23M | -2.56M | -3.82M | 380.00K | 1.75M | -663.00K | -2.77M | -4.17M | -3.92M | -3.58M |
| Net Income growth (YoY) | — | — | -1105.00% | -78.35% | — | — | — | — | — | — |
| EPS (Basic) | -4.12 | -34.87 | -36.39 | -0.01 | -0.04 | 0.02 | 0.07 | 0.10 | 0.10 | 0.09 |
| EPS (Diluted) | — | -34.87 | -36.39 | -0.01 | -0.04 | 0.02 | 0.07 | 0.10 | 0.10 | 0.09 |
| Shares Outstanding (Basic) | 5.32M | 157.61K | 157.61K | 54.38K | 47.17K | 40.88M | 40.88M | 40.88M | 40.88M | 40.88K |
| Shares Outstanding (Diluted) | — | 157.61K | 157.61K | 54.38K | 47.17K | 40.88M | 40.88M | 40.88M | 40.88M | 40.88K |
| EBITDA | -10.60M | -328.00K | -795.00K | — | — | — | — | — | — | — |
| Gross Margin | 23.02% | 21.33% | 19.88% | — | — | — | — | — | — | — |
| Operating Margin | -23.43% | -142.00% | -2.60% | -9.05% | — | — | — | — | — | — |
| Net Margin | -45.28% | -5.71% | -7.90% | -19.00% | — | — | — | — | — | — |
This table shows 10 annual periods of Capstone's income statement, from FY 2025 back to FY 2012, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a income statement?